The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 17, 2009
Filed:
Mar. 24, 2003
Greta Van Den Berghe, Grez-Doiceau, BE;
Daniel Berckmans, Kessel-Lo, BE;
Jean-marie Aerts, Haasrode, BE;
Bart DE Moor, Bierbeek, BE;
Bert Pluymers, Westerlo, BE;
Frank DE Smet, Mechelen, BE;
Greta Van Den Berghe, Grez-Doiceau, BE;
Daniel Berckmans, Kessel-Lo, BE;
Jean-Marie Aerts, Haasrode, BE;
Bart De Moor, Bierbeek, BE;
Bert Pluymers, Westerlo, BE;
Frank De Smet, Mechelen, BE;
K.U. Leuven Research & Development, Leuven, BE;
Abstract
Present invention is a system of blood glucose monitoring and intensive insulin therapy in a ICU for strict maintenance of normoglycemia which reduces intensive care and hospital mortality and morbidity of critically ill adult patients. The findings of present study also reveal factors determining insulin doses needed to maintain normoglycemia as well as the impact of insulin dose versus blood glucose level on the observed outcome benefits have been established. The invention provides a control system that adapts the flow of the insulin infusion based on insulin requirement calculated by blood glucose levels and clinical parameters such as history of diabetes, Body Mass Index, blood glucose level on admission, reason of ICU admission, time in the ICU, type and severity of illness, caloric intake, obesity, drugs affecting insulin sensitivity). This automated insulin monitoring systems significantly reduces the workload and human resource management problems for intensive insulin therapy in patients in the ICU.